Video Lectures
State-of-the-industry video lectures by leading urology experts
Latest Videos

TAIPEI, TAIWAN ( - Introduction and Objectives: The most important modifiable risk factors for kidney function after partial nephrectomy (PN) are the quantity of parenchyma removed and the length of warm ischemia time (WIT). In this study, we further investigate the effects of WIT on renal function by comparing PN patients to completely healthy patients undergoing total donor nephrectomy (DN).

wceMethods: We performed a retrospective review of 92 PN and 242 DN patients at a single academic institution. Baseline characteristics, WIT, and follow-up serum Creatinine (sCr) at discharge, 1–7 months and at last follow-up were compared. Estimated GFR (eGFR) was calculated using sCr and the Modification of Diet on Renal Disease (MDRD) formula. Data was analyzed using the Mann-Whitney U and Chi-square tests as appropriate.

Results: The DN patients were younger (37.4 vs. 60.2; p < 0.001), and had lower EBL(103.0 vs. 287.9; p < 0.001), BMI(26.5 vs. 30.8; p < 0.001), and ASA(1 vs. 2.7; p < 0.001). They were also less likely to require transfusions intraoperatively (p = 0.001) and had higher preoperative eGFR(101.6 vs. 78.1; p < 0.001). In the PN cohort, the median tumor size was 3.2 cm and mean WIT was 27.9 minutes. DN patients were found to have greater eGFR decline upon discharge ( - 46.7% vs. - 4.2%, p < 0.001), at 1–7 month postoperatively ( - 36.9% vs. - 5.5%; p < 0.001) and at the latest follow-up ( - 38.0% vs. - 2.4%; p < 0.001).

Conclusions: In the PN cohort, warm ischemia in patients with greater medical comorbidity resulted in much less decrease in GFR than a total nephrectomy performed in a completely healthy donor population. The primary concern for surgeons performing partial nephrectomy should be renal preservation not warm ischemia time.

Source of Funding: None

Listen to an interview with Javier Arenas, one of the authors of this study.


Presented by Daniel Faaborg, Roger Li, Herbert C. Ruckle, Jared Schober, Michelle Lightfoot, Muhannad Alsyouf, Phillip Stokes, David Culpepper, David Tryon, Gene O. Huang, Javier Arenas, and D. Duane Baldwin at the 32nd World Congress of Endourology & SWL- September 3 - 7, 2014 - Taipei, Taiwan

Loma Linda University Medical Center, Loma Linda, CA USA 


Upcoming urology industry events
February 24, 2018 / Charleston Marriott
Advances in Cancer Immunotherapy™ - Charleston, SC
February 24, 2018 /
2018 IUA Annual Meeting
February 26-27, 2018 / The Royal Marsden Hospital
MediSens – The European Medical Imaging Conference
February 27-March 3, 2018 /
SUFU 2018 Winter Meeting
March 1-3, 2018 / Omni Amelia Island Plantation Resort, Fernandina Beach, FL
75th Annual Meeting Mid-Atlantic Section of the American Urological Association
Print publications focusing on urological cancer treatments through original commentary & articles

Everyday Urology™ - Oncology Insights

From the Editor

Prostate Cancer and Prostatic Diseases

From the Editor